Product Reports Resources Pricing Login Book a demo

PaloBiofarma

Biotech & Life Sciences · Noáin (Valle de Elorz)/Noain (Elortzibar), Spain · Founded 2006

A company with the ambition to develop new treatments for cancer and autoimmune diseases based on adenosine receptor modulation MoreLess

Developer of drugs intended to cure diseases based on the modulation of adenosine receptors. The company focuses to discover the first marketed drug based on a selective adenosine receptor modulator leveraging medicinal chemistry and in vitro pharmacology of adenosine, enabling doctors to focus on the treatment of advanced prostate cancer. Keywords: Pharmaceuticals and Biotechnology, Adenosine Pharmaceutical, Adenosine Receptor, Cancer Therapy, Cancer Treatment, Clinical Development, Medical Services.

Valuation $0–100M
Revenue <$1M
Headcount <100
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PaloBiofarma and the history behind them.

Talent graph

PaloBiofarma's talent

Book a demo to see the people
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on PaloBiofarma's cap table

Sourced from Dealroom's funding and investor records.

Seed 3 investors entered at this stage
Inveready
Fitalent
European Innovation Council
Series A 2 investors entered at this stage
Sodena
Foundation for Prader-Willi Syndrome Research
Series B+ 1 investor entered at this stage
Asabys Partners

Global footprint

Where PaloBiofarma has talent and traffic

Workforce by country
2 countries with
team presence
🇪🇸 Spain90%
🇩🇪 Germany10%
2 countries shown

Market sentiment

What the market is saying about PaloBiofarma

An AI-synthesized read of the highest-engagement posts about PaloBiofarma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PaloBiofarma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles